Evaluation the Impact of Self-Stigma Reduction Program on Psychosocial Outcomes Among People Diagnosed With Schizophrenia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Stigmatization
- Sponsor
- Fakeeh College for Medical Sciences
- Enrollment
- 278
- Locations
- 1
- Primary Endpoint
- The primary outcome was stigma perception measured by the Internalised Stigma of Mental Illness Scale (ISMI)
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Backgrounds: Research evidence suggests that people diagnosed with schizophrenia (PDwS) experience higher level of stigma compared with other forms of mental illness, and they are prone to internalize stereotype, which exacerbates severity of psychiatric symptoms, reduces their psychosocial treatment adherence. The purpose of the study to evaluate the effectiveness of stigma reduction program on the perceived stigma, psychiatric symptoms, compliance with psychosocial intervention and self-efficacy.
Methods: A randomized controlled trial was conducted from November 2017 to December 2018 with 278 PDwS. Participants aged 18 years or older with DSM-IV schizophrenia or schizoaffective disorder, from four outpatient mental health clinics in Jordan, were randomly assigned to receive 13 sessions of a booklet form of stigma reduction program (n = 140) (psycho-education, cognitive behavioural therapy and social skills training), and treatment as usual [TAU] (intervention, n = 140), or TAU (control, n = 138). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at six months follow-up. The primary outcome measure was change in stigma perception. Secondary outcomes were psychiatric symptoms, compliance with psychosocial interventions and self-efficacy.
Investigators
Abd Alhadi Hasan
Assistant professor
Fakeeh College for Medical Sciences
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
The primary outcome was stigma perception measured by the Internalised Stigma of Mental Illness Scale (ISMI)
Time Frame: November 2017-December 2018 (up to 11 months)
The primary outcome was stigma perception measured by the Internalised Stigma of Mental Illness Scale (ISMI). This scale has 29 items measure service user experience of stigma. It is composed of 5 subscales: alienation (6 items), stereotype endorsement (7 items), discrimination experience (5 items), social withdrawal (6 items), and stigma resistance (5 items). Each item is rated on a four-point Likert scale from 1 (strongly disagree) to 4 (strongly agree). The five stigma resistance subscale items are reverse-coded, and also serve as a validity check. The stigma resistance score is calculated by subtracting the actual value from five. Therefore, stigma resistance displays the same direction of correlation as the other four subscales. A high total score on the ISMI scale indicates more severe internalized stigmatization. The internal consistency is (α=0.90) and test-retest reliability (r=0.92) have been reported for the ISMI (Ritsher \& Phelan, 2004).
Secondary Outcomes
- The Chinese General Self-efficacy Scale (CGSS)(November 2017-December 2018 (up to 11 months))
- Positive and Negative Symptom Scale (PANSS)(November 2017-December 2018 (up to 11 months))
- The Psychosocial Treatment Compliance Scale (PTCS)(November 2017-December 2018 (up to 11 months))